Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Post by MoneyMouthon Apr 20, 2021 12:50pm
181 Views
Post# 33029803

Next seven months could get interesting...

Next seven months could get interesting...If sernova actually comes through with all of the claims they made about what they want to achieve this year. I mean we are almost in the 5th month of the year. If we get a news drought in May, then that gives them 6 months to drop some power bomb's in the form of but not limited to:
  • Complete FDA Diabetes Trial Enrollment
  • Begin Clinical Study on Immune Protection Tech
  • Begin Clinical Study on Thyroid Treatment
  • Begin Clinical Study on Hemophilia Treatment
  • Upgrade To A Better Stock Exchange
  • Secure A Licensing Deal
  • Provide FDA trial results
That's 7 catalysts. I doubt they will be able to come through on all 7 this year. But regarding the Clinical Studies, I wonder what the lead times are on FDA submissions. I'd imagine the FDA is slammed and even if Sernova submitted a regulatory package for a clinical study, I bet the wait times could be pretty substantial. Is there anything wrong with Sernova letting us know if they've submitted a package or not? Like that'd be a non-fluff news release in itself, but they'd never do it. They'll leave us in the dark until the trial is actually approved. But why?


<< Previous
Bullboard Posts
Next >>